These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25948775)

  • 1. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
    Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
    Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.
    Palii SS; Van Emburgh BO; Sankpal UT; Brown KD; Robertson KD
    Mol Cell Biol; 2008 Jan; 28(2):752-71. PubMed ID: 17991895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal.
    Ghoshal K; Datta J; Majumder S; Bai S; Kutay H; Motiwala T; Jacob ST
    Mol Cell Biol; 2005 Jun; 25(11):4727-41. PubMed ID: 15899874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.
    Datta J; Ghoshal K; Denny WA; Gamage SA; Brooke DG; Phiasivongsa P; Redkar S; Jacob ST
    Cancer Res; 2009 May; 69(10):4277-85. PubMed ID: 19417133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.
    Schmelz K; Wagner M; Dörken B; Tamm I
    Int J Cancer; 2005 May; 114(5):683-95. PubMed ID: 15609309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1.
    Maslov AY; Lee M; Gundry M; Gravina S; Strogonova N; Tazearslan C; Bendebury A; Suh Y; Vijg J
    Oncogene; 2012 Dec; 31(50):5172-9. PubMed ID: 22349820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors.
    Beyrouthy MJ; Garner KM; Hever MP; Freemantle SJ; Eastman A; Dmitrovsky E; Spinella MJ
    Cancer Res; 2009 Dec; 69(24):9360-6. PubMed ID: 19951990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine.
    Thottassery JV; Sambandam V; Allan PW; Maddry JA; Maxuitenko YY; Tiwari K; Hollingshead M; Parker WB
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):291-302. PubMed ID: 24908436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors.
    Laranjeira ABA; Hollingshead MG; Nguyen D; Kinders RJ; Doroshow JH; Yang SX
    Sci Rep; 2023 Apr; 13(1):5964. PubMed ID: 37045940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells.
    Yang J; Tian X; Yang J; Cui J; Jiang S; Shi R; Liu Y; Liu X; Xu W; Xie W; Jia X; Bade R; Zhang T; Zhang M; Gong K; Yan S; Yang Z; Shao G
    J Toxicol Environ Health A; 2017; 80(22):1222-1229. PubMed ID: 28880816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers.
    Yun J; Song SH; Park J; Kim HP; Yoon YK; Lee KH; Han SW; Oh DY; Im SA; Bang YJ; Kim TY
    Lab Invest; 2012 Jul; 92(7):1033-44. PubMed ID: 22508389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.
    Link PA; Baer MR; James SR; Jones DA; Karpf AR
    Cancer Res; 2008 Nov; 68(22):9358-66. PubMed ID: 19010910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme.
    Patel K; Dickson J; Din S; Macleod K; Jodrell D; Ramsahoye B
    Nucleic Acids Res; 2010 Jul; 38(13):4313-24. PubMed ID: 20348135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells.
    Yan F; Shen N; Pang J; Molina JR; Yang P; Liu S
    J Biol Chem; 2015 Jul; 290(30):18480-94. PubMed ID: 26085088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
    Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
    Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines.
    Hagemann S; Heil O; Lyko F; Brueckner B
    PLoS One; 2011 Mar; 6(3):e17388. PubMed ID: 21408221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-aza-2'-deoxycytidine leads to reduced embryo implantation and reduced expression of DNA methyltransferases and essential endometrial genes.
    Ding YB; Long CL; Liu XQ; Chen XM; Guo LR; Xia YY; He JL; Wang YX
    PLoS One; 2012; 7(9):e45364. PubMed ID: 23028963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.
    Jung Y; Park J; Kim TY; Park JH; Jong HS; Im SA; Robertson KD; Bang YJ; Kim TY
    J Mol Med (Berl); 2007 Oct; 85(10):1137-48. PubMed ID: 17571247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
    Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
    Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.